Can a simple paper tool help melanoma patients make tough biopsy decisions?
NCT ID NCT07653087
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a paper-based decision aid designed to help people with intermediate-risk melanoma decide whether to have a sentinel lymph node biopsy. The tool provides clear information about the procedure, its risks and benefits, and helps patients think about their personal preferences. Researchers want to see if using the aid reduces uncertainty and improves knowledge about the biopsy decision.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Decision aid (paper-based informational tool)
What this could lead to
If effective, this decision aid could help patients and doctors make more confident, informed choices about sentinel lymph node biopsy for melanoma.
What could go wrong
This is a small, early-stage study focused on decision-making, not treatment outcomes. The tool may not reduce anxiety or improve decisions for all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA (SKIN CANCER) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Virginia Health System
Charlottesville, Virginia, 22908, United States